Safest Beta-Blocker in Pregnancy
Labetalol and metoprolol are the safest beta-blockers for use during pregnancy, with labetalol having the advantage of vasodilation through combined alpha-beta blockade, while atenolol should be strictly avoided due to significant risk of fetal growth restriction.
First-Line Beta-Blocker Recommendations
Labetalol is consistently recommended as a first-line antihypertensive agent across multiple major guidelines 1, 2, 3. The typical dosing ranges from 100 mg twice daily up to 2400 mg per day 1. It has extensive safety data with no evidence of teratogenicity 1. The combined alpha-beta blocking properties provide vasodilation, which is theoretically advantageous during pregnancy 1.
Metoprolol is also considered a safe first-line agent with a longer safety record 4, 5. It is preferred over other beta-blockers for chronic prophylaxis because of established safety data 4. The 2020 Hypertension Canada guidelines specifically list metoprolol among first-line oral drugs for pregnancy 2.
Other acceptable beta-blockers include propranolol, pindolol, and acebutolol, all of which are listed as first-line options in major guidelines 2, 6.
Critical Contraindication: Atenolol
Atenolol must be avoided during pregnancy 4, 6, 4, 6. Multiple guidelines classify atenolol as FDA Category D and explicitly recommend against its use 6. The evidence shows:
- Growth retardation in babies receiving atenolol in the first trimester 6
- Higher prevalence of preterm delivery 6
- Risk is especially pronounced when started earlier in gestational age and used for longer duration 4
- One study found 33% incidence of fetal growth restriction with atenolol 7
Timing Considerations
Avoid beta-blockers in the first trimester when possible 4, 6, 4, 6. The risk of congenital malformations is greatest during this period 4. If treatment is necessary before conception or in early pregnancy, the benefits must clearly outweigh risks.
Important Caveats About All Beta-Blockers
While labetalol and metoprolol are the safest options, all beta-blockers carry some risk of:
- Intrauterine growth restriction - This is a class effect, though significantly more pronounced with atenolol 4, 8, 7
- Fetal bradycardia 2, 6
- Neonatal hypoglycemia 6
- Potential effects on fetal heart rate requiring monitoring 5
A Japanese study found fetal growth restriction rates of 36% with propranolol, 17% with metoprolol, 33% with atenolol, and 0% with bisoprolol (though bisoprolol data is limited) 7. Notably, carvedilol (an alpha-beta blocker like labetalol) showed no association with fetal growth restriction in this study 7.
Practical Algorithm for Selection
- First choice: Labetalol (100 mg BID, titrate up to 2400 mg/day) - especially if patient needs vasodilation or has no contraindications
- Alternative first choice: Metoprolol - if labetalol causes headaches, tachycardia, or edema, or if patient has reactive airway disease (contraindication to labetalol)
- Second-line options: Propranolol, pindolol, or acebutolol if first-line agents fail
- Never use: Atenolol at any point during pregnancy
Monitoring Requirements
When using any beta-blocker during pregnancy:
- Monitor fetal growth closely, particularly in second and third trimesters 5
- Assess for fetal bradycardia 2, 5
- Consider more frequent ultrasounds to evaluate fetal development
- Be prepared to adjust or discontinue if growth restriction develops
The evidence consistently supports labetalol and metoprolol as having the best safety profiles, with the critical caveat that atenolol is contraindicated and all beta-blockers require careful fetal monitoring for growth restriction 1, 2, 4, 6, 4, 5, 6.